Chittaranjan Andrade, MD
Clinical and Practical Psychopharmacology
Prolactin, Antipsychotics, and Fracture Risk
January 30, 2023
Fracture risk associated with antipsychotics may be related to whether they increase prolactin. If long-term treatment with prolactin-raising agents is necessary, prolactin levels should be regularly monitored.
Clinical and Practical Psychopharmacology
How to Critically Read a Study of Adverse Outcomes With Antidepressant Use
December 7, 2022
Chittaranjan Andrade, MD, explains how to think critically about a study covered in the media. Concepts include confounding by indication, regression, and how to deal with confounding.
Clinical and Practical Psychopharmacology
The Practical Importance of Half-Life in Psychopharmacology
July 25, 2022
Essential information on why it’s important to know the half-lives of drugs, how half-life may differ with individual patient characteristics, and how to use this knowledge to best advantage...
Clinical and Practical Psychopharmacology
ADHD, ASD, and Other Neurodevelopmental Outcomes Associated With Antipsychotic Exposure During Pregnancy
May 30, 2022
Dr Andrade discusses the implications of 2 recent large cohort studies examining risk of neurodevelopmental disorders after gestational exposure to antidepressants.
Clinical and Practical Psychopharmacology
Antidepressant Drugs and Health-Related QoL: A Guide to Examining a “Viral” Research Paper
May 25, 2022
A recent study reporting no improvement in health-related quality of life with antidepressants went “viral” in the mass media. Here, Dr Andrade considers the shortcomings of the study and...
